Literature DB >> 19568696

The role of transporters in the pharmacokinetics of orally administered drugs.

Sarah Shugarts1, Leslie Z Benet.   

Abstract

Drug transporters are recognized as key players in the processes of drug absorption, distribution, metabolism, and elimination. The localization of uptake and efflux transporters in organs responsible for drug biotransformation and excretion gives transporter proteins a unique gatekeeper function in controlling drug access to metabolizing enzymes and excretory pathways. This review seeks to discuss the influence intestinal and hepatic drug transporters have on pharmacokinetic parameters, including bioavailability, exposure, clearance, volume of distribution, and half-life, for orally dosed drugs. This review also describes in detail the Biopharmaceutics Drug Disposition Classification System (BDDCS) and explains how many of the effects drug transporters exert on oral drug pharmacokinetic parameters can be predicted by this classification scheme.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19568696      PMCID: PMC2719753          DOI: 10.1007/s11095-009-9924-0

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  163 in total

1.  Effect of SLCO1B1 genetic polymorphism on the pharmacokinetics of nateglinide.

Authors:  Wei Zhang; Yi-Jing He; Chun-Ting Han; Zhao-Qian Liu; Qing Li; Lan Fan; Zhi-Rong Tan; Wei-Xia Zhang; Bang-Ning Yu; Dan Wang; Dong-Li Hu; Hong-Hao Zhou
Journal:  Br J Clin Pharmacol       Date:  2006-06-23       Impact factor: 4.335

2.  Modulation by drugs of human hepatic sodium-dependent bile acid transporter (sodium taurocholate cotransporting polypeptide) activity.

Authors:  R B Kim; B Leake; M Cvetkovic; M M Roden; J Nadeau; A Walubo; G R Wilkinson
Journal:  J Pharmacol Exp Ther       Date:  1999-12       Impact factor: 4.030

3.  Pharmacogenetics of SLCO1B1 gene and the impact of *1b and *15 haplotypes on irinotecan disposition in Asian cancer patients.

Authors:  Xiaoqiang Xiang; Srinivasa Rao Jada; Hui Hua Li; Lu Fan; Lai San Tham; Chiung Ing Wong; Soo Chin Lee; Robert Lim; Qing Yu Zhou; Boon Cher Goh; Eng Huat Tan; Balram Chowbay
Journal:  Pharmacogenet Genomics       Date:  2006-09       Impact factor: 2.089

4.  Monocarboxylate transporter 1 (MCT1) plays a direct role in short-chain fatty acids absorption in caprine rumen.

Authors:  Doaa Kirat; Junji Masuoka; Hideaki Hayashi; Hidetomo Iwano; Hiroshi Yokota; Hiroyuki Taniyama; Seiyu Kato
Journal:  J Physiol       Date:  2006-08-10       Impact factor: 5.182

5.  Distribution of monocarboxylate transporters MCT1-MCT8 in rat tissues and human skeletal muscle.

Authors:  Arend Bonen; Miriam Heynen; Hideo Hatta
Journal:  Appl Physiol Nutr Metab       Date:  2006-02       Impact factor: 2.665

6.  Expression, localisation and activity of ATP binding cassette (ABC) family of drug transporters in human amnion membranes.

Authors:  I L M H Aye; J W Paxton; D A Evseenko; J A Keelan
Journal:  Placenta       Date:  2007-05-07       Impact factor: 3.481

Review 7.  Effects of drug transporters on volume of distribution.

Authors:  Anita Grover; Leslie Z Benet
Journal:  AAPS J       Date:  2009-04-28       Impact factor: 4.009

8.  SLCO1B1 (OATP1B1, an uptake transporter) and ABCG2 (BCRP, an efflux transporter) variant alleles and pharmacokinetics of pitavastatin in healthy volunteers.

Authors:  I Ieiri; S Suwannakul; K Maeda; H Uchimaru; K Hashimoto; M Kimura; H Fujino; M Hirano; H Kusuhara; S Irie; S Higuchi; Y Sugiyama
Journal:  Clin Pharmacol Ther       Date:  2007-04-25       Impact factor: 6.875

9.  Human organic anion transporter 1B1 and 1B3 function as bidirectional carriers and do not mediate GSH-bile acid cotransport.

Authors:  Chitrawina Mahagita; Steven M Grassl; Pawinee Piyachaturawat; Nazzareno Ballatori
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-04-05       Impact factor: 4.052

10.  Using novobiocin as a specific inhibitor of breast cancer resistant protein to assess the role of transporter in the absorption and disposition of topotecan.

Authors:  Yaming Su; Peidi Hu; Sung-Hack Lee; Patrick J Sinko
Journal:  J Pharm Pharm Sci       Date:  2007       Impact factor: 2.327

View more
  106 in total

Review 1.  Improving the prediction of the brain disposition for orally administered drugs using BDDCS.

Authors:  Fabio Broccatelli; Caroline A Larregieu; Gabriele Cruciani; Tudor I Oprea; Leslie Z Benet
Journal:  Adv Drug Deliv Rev       Date:  2011-12-21       Impact factor: 15.470

Review 2.  Coexistence of passive and carrier-mediated processes in drug transport.

Authors:  Kiyohiko Sugano; Manfred Kansy; Per Artursson; Alex Avdeef; Stefanie Bendels; Li Di; Gerhard F Ecker; Bernard Faller; Holger Fischer; Grégori Gerebtzoff; Hans Lennernaes; Frank Senner
Journal:  Nat Rev Drug Discov       Date:  2010-08       Impact factor: 84.694

Review 3.  BDDCS Predictions, Self-Correcting Aspects of BDDCS Assignments, BDDCS Assignment Corrections, and Classification for more than 175 Additional Drugs.

Authors:  Chelsea M Hosey; Rosa Chan; Leslie Z Benet
Journal:  AAPS J       Date:  2015-11-20       Impact factor: 4.009

Review 4.  Drug transporters in tissues and cells relevant to sexual transmission of HIV: Implications for drug delivery.

Authors:  Minlu Hu; Sravan Kumar Patel; Tian Zhou; Lisa C Rohan
Journal:  J Control Release       Date:  2015-08-13       Impact factor: 9.776

Review 5.  Reliability of In Vitro and In Vivo Methods for Predicting the Effect of P-Glycoprotein on the Delivery of Antidepressants to the Brain.

Authors:  Yi Zheng; Xijing Chen; Leslie Z Benet
Journal:  Clin Pharmacokinet       Date:  2016-02       Impact factor: 6.447

6.  Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS).

Authors:  Manthena V Varma; Stefanus J Steyn; Charlotte Allerton; Ayman F El-Kattan
Journal:  Pharm Res       Date:  2015-07-09       Impact factor: 4.200

7.  Applying Biopharmaceutical Classification System (BCS) Criteria to Predict Oral Absorption of Drugs in Dogs: Challenges and Pitfalls.

Authors:  Mark G Papich; Marilyn N Martinez
Journal:  AAPS J       Date:  2015-04-29       Impact factor: 4.009

Review 8.  Predicting drug disposition via application of a Biopharmaceutics Drug Disposition Classification System.

Authors:  Leslie Z Benet
Journal:  Basic Clin Pharmacol Toxicol       Date:  2009-12-07       Impact factor: 4.080

9.  Characterization of the transmembrane transport and absolute bioavailability of the HCV protease inhibitor danoprevir.

Authors:  Barbara J Brennan; Agnès Poirier; Sebastian Moreira; Peter N Morcos; Petra Goelzer; Renée Portmann; Jiney Asthappan; Christoph Funk; Patrick F Smith
Journal:  Clin Pharmacokinet       Date:  2015-05       Impact factor: 6.447

10.  Translation in Data Mining to Advance Personalized Medicine for Health Equity.

Authors:  Estela S Estape; Mary Helen Mays; Elizabeth A Sternke
Journal:  Intell Inf Manag       Date:  2016-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.